A modern view on the role of single nucleotide polymorphism of human genes in the formation of unfavorable consequences of the new coronavirus disease (COVID-19)
DOI:
https://doi.org/10.14739/2310-1210.2024.5.307248Keywords:
coronavirus disease, COVID-19, viral infection, single nucleotide polymorphism, clinic, diagnosis, prognosisAbstract
Aim – to analyze the current literature on the role of single nucleotide polymorphism (SNP) of human genes in shaping the clinical course of the new coronavirus disease (COVID-19).
Results. Based on the results of the analysis and synthesis of the current literature on the role of SNP in shaping the clinical course and outcome of COVID-19, the clinical and prognostic significance of SNP of genes encoding receptors responsible for the penetration of SARS-CoV-2 into target cells has been demonstrated. The presence of the D-allele of the ACE gene (DD and ID genotypes) is associated with the highest risk of severe COVID-19, which makes it possible to offer it as an informative prognostic marker of COVID-19 severity. SNP of the TMPRSS2 co-receptor gene, known as the androgen responsive gene, at certain loci is prognostically important, as it leads to an increase in TMPRSS2 expression in men, which promotes virus fusion with the target cell membrane and has an unfavorable effect on the course of COVID-19 in men.
The data accumulated in the current literature on the clinical and prognostic value of SNP host genes encoding the immune response has also been analyzed. The role of HLA SNP genes, genes encoding innate immunity factors (TLR), as well as genes encoding pro-inflammatory cytokines (IL-6, TNF-α, etc.) and acute-phase inflammatory components (CRP) in the development of severe COVID-19 and the risk of death has been demonstrated. Attention has been paid to the determined role of SNP in the ACE gene in the development of pulmonary embolism in patients with severe COVID-19. The article has analyzed publications on the SNP role of host genes in the development of clinical events that are currently interpreted as long COVID. The prognostic role of the IL-10 gene SNP and its receptor gene in the formation of long-term consequences of the new coronavirus infection has been demonstrated.
Conclusions. SNP of host genes encoding receptors responsible for the entry of SARS-CoV-2 into target cells and SNP of genes encoding immune response have some prognostic value in assessing the risk of severe course and adverse effects of COVID-19. The accumulation of data on genetic risk factors for adverse outcomes of the new coronavirus disease will allow us to enhance the understanding of this infection pathogenesis, improve patient stratification and individualize therapeutic interventions.
References
Mukherjee S, Huda S, Sinha Babu SP. Toll-like receptor polymorphism in host immune response to infectious diseases: A review. Scand J Immunol. 2019;90(1):e12771. doi: https://doi.org/10.1111/sji.12771
Keshavarz M, Namdari H, Farahmand M, Mehrbod P, Mokhtari-Azad T, Rezaei F. Association of polymorphisms in inflammatory cytokines encoding genes with severe cases of influenza A/H1N1 and B in an Iranian population. Virol J. 2019;16(1):79. doi: https://doi.org/10.1186/s12985-019-1187-8
Naranjo-Galvis CA, de-la-Torre A, Mantilla-Muriel LE, Beltrán-Angarita L, Elcoroaristizabal-Martín X, McLeod R, et al. Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular Toxoplasmosis. Infect Immun. 2018;86(4):e00597-17. doi: https://doi.org/10.1128/IAI.00597-17
Zhang M, Xu J, Bao X, Niu W, Wang L, Du L, et al. Association between Genetic Polymorphisms in Interleukin Genes and Recurrent Pregnancy Loss - A Systematic Review and Meta-Analysis. PLoS One. 2017;12(1):e0169891. doi: https://doi.org/10.1371/journal.pone.0169891
Chen Y, Hu Y, Song Z. The association between interleukin-6 gene -174G/C single nucleotide polymorphism and sepsis: an updated meta-analysis with trial sequential analysis. BMC Med Genet. 2019;20(1):35. doi: https://doi.org/10.1186/s12881-019-0766-2
Wang J, Fan N, Deng Y, Zhu J, Mei J, Chen Y, Yang H. Association between genetic polymorphisms of interleukins and cerebral infarction risk: a meta-analysis. Biosci Rep. 2016;36(6):e00404. doi: https://doi.org/10.1042/BSR20160226
Hishida A, Okugawa Y, Morimoto Y, Shirai Y, Okamoto K, Momokita S, et al. Genetic influence of cytokine polymorphisms on the clinical outcome of Japanese gastrointestinal cancer patients in palliative care. Oncol Lett. 2019;17(1):623-9. doi: https://doi.org/10.3892/ol.2018.9614
Alipoor SD, Mortaz E, Jamaati H, Tabarsi P, Bayram H, Varahram M, et al. COVID-19: Molecular and Cellular Response. Front Cell Infect Microbiol. 2021;11:563085. doi: https://doi.org/10.3389/fcimb.2021.563085
Rithanya M, Brundha MP. Molecular Immune Pathogenesis and Diagnosis of COVID-19 - A Review. Int J Cur Res Rev. 2020;12(21):69-73. doi: https://doi.org/10.31782/ijcrr.2020.sp37
Gupta K, Kaur G, Pathak T, Banerjee I. Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity. Gene. 2022;844:146790. doi: https://doi.org/10.1016/j.gene.2022.146790
David S, Dorado G, Duarte EL, David-Bosne S, Trigueiro-Louro J, Rebelo-de-Andrade H. COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity. Immunogenetics. 2022;74(4):381-407. doi: https://doi.org/10.1007/s00251-022-01261-w
Adli A, Rahimi M, Khodaie R, Hashemzaei N, Hosseini SM. Role of genetic variants and host polymorphisms on COVID-19: From viral entrance mechanisms to immunological reactions. J Med Virol. 2022;94(5):1846-65. doi: https://doi.org/10.1002/jmv.27615
Scaramuzzo G, Nucera F, Asmundo A, Messina R, Mari M, Montanaro F, et al. Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance. J Inflamm (Lond). 2023;20(1):11. doi: https://doi.org/10.1186/s12950-023-00333-2
Singh H, Choudhari R, Nema V, Khan AA. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease. Microb Pathog. 2021;150:104621. doi: https://doi.org/10.1016/j.micpath.2020.104621
Gard PR. Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review. Int J Mol Epidemiol Genet. 2010;1(2):145-57.
Delanghe JR, Speeckaert MM, De Buyzere ML. The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections. Clin Chim Acta. 2020;505:192-3. doi: https://doi.org/10.1016/j.cca.2020.03.031
Kenyon C. ACE-1 I/D Polymorphism Associated with COVID-19 Incidence and Mortality: An Ecological Study. Preprints. 2020;19(April),1-37. https://doi.org/10.20944/preprints202004.0262.v1
Yamamoto N, Ariumi Y, Nishida N, Yamamoto R, Bauer G, Gojobori T, et al. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype. Gene. 2020;758:144944. doi: https://doi.org/10.1016/j.gene.2020.144944
Wang J, Xu X, Zhou X, Chen P, Liang H, Li X, et al. Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection. J Gen Virol. 2020;101(9):921-4. doi: https://doi.org/10.1099/jgv.0.001452
Srivastava A, Bandopadhyay A, Das D, Pandey RK, Singh V, Khanam N, et al. Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in India. Front Genet. 2020;11:564741. doi: https://doi.org/10.3389/fgene.2020.564741
Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181-92. doi: https://doi.org/10.1038/s41579-018-0118-9
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280.e8. doi: https://doi.org/10.1016/j.cell.2020.02.052
Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY). 2020;12(11):10087-98. doi: https://doi.org/10.18632/aging.103415
Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention? Cancer Discov. 2020;10(6):779-82. doi: https://doi.org/10.1158/2159-8290.CD-20-0451
Tudorache IF, Trusca VG, Gafencu AV. Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features. Comput Struct Biotechnol J. 2017;15:359-65. doi: https://doi.org/10.1016/j.csbj.2017.05.003
Kuhlmann I, Minihane AM, Huebbe P, Nebel A, Rimbach G. Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis. 2010;9:8. doi: https://doi.org/10.1186/1476-511X-9-8
Gkouskou K, Vasilogiannakopoulou T, Andreakos E, Davanos N, Gazouli M, Sanoudou D, et al. COVID-19 enters the expanding network of apolipoprotein E4-related pathologies. Redox Biol. 2021;41:101938. doi: https://doi.org/10.1016/j.redox.2021.101938
Zunec R. A review of HLA and COVID-19 association studies. Molecular and experimental biology in medicine. 2020;3(2):25-30. doi: https://doi.org/10.33602/mebm.3.2.3
Nguyen A, David JK, Maden SK, Wood MA, Weeder BR, Nellore A, Thompson RF. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2. J Virol. 2020;94(13):e00510-20. doi: https://doi.org/10.1128/JVI.00510-20
Weiner J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, Müller M, et al. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. 2021;40:101099. doi: https://doi.org/10.1016/j.eclinm.2021.101099
Ahluwalia TS, Prins BP, Abdollahi M, Armstrong NJ, Aslibekyan S, Bain L, et al. Genome-wide association study of circulating interleukin 6 levels identifies novel loci. Hum Mol Genet. 2021;30(5):393-409. doi: https://doi.org/10.1093/hmg/ddab023
Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol. 2022;23(2):165-76. doi: https://doi.org/10.1038/s41590-021-01091-0
Paludan SR, Mogensen TH. Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol. 2022;7(67):eabm5505. doi: https://doi.org/10.1126/sciimmunol.abm5505
Bakaros E, Voulgaridi I, Paliatsa V, Gatselis N, Germanidis G, Asvestopoulou E, et al. Innate Immune Gene Polymorphisms and COVID-19 Prognosis. Viruses. 2023;15(9):1784. doi: https://doi.org/10.3390/v15091784
Spence JS, He R, Hoffmann HH, Das T, Thinon E, Rice CM, et al. IFITM3 directly engages and shuttles incoming virus particles to lysosomes. Nat Chem Biol. 2019;15(3):259-68. doi: https://doi.org/10.1038/s41589-018-0213-2
Bailey CC, Zhong G, Huang IC, Farzan M. IFITM-Family Proteins: The Cell's First Line of Antiviral Defense. Annu Rev Virol. 2014;1:261-83. doi: https://doi.org/10.1146/annurev-virology-031413-085537
Prabhu SS, Chakraborty TT, Kumar N, Banerjee I. Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: A meta-analysis. Gene. 2018;674:70-9. doi: https://doi.org/10.1016/j.gene.2018.06.070
Banday AR, Stanifer ML, Florez-Vargas O, Onabajo OO, Papenberg BW, Zahoor MA, et al. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries. Nat Genet. 2022;54(8):1103-16. doi: https://doi.org/10.1038/s41588-022-01113-z
Kousathanas A, Pairo-Castineira E, Rawlik K, Stuckey A, Odhams CA, Walker S, et al. Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature. 2022;607(7917):97-103. doi: https://doi.org/10.1038/s41586-022-04576-6
Saleh A, Sultan A, Elashry MA, Farag A, Mortada MI, Ghannam MA, et al. Association of TNF-α G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients. Immunol Invest. 2022;51(3):546-57. doi: https://doi.org/10.1080/08820139.2020.1851709
Cantalupo S, Lasorsa VA, Russo R, Andolfo I, D'Alterio G, Rosato BE, et al. Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19. Int J Mol Sci. 2021;22(10):5372. doi: https://doi.org/10.3390/ijms22105372
Stringer D, Braude P, Myint PK, Evans L, Collins JT, Verduri A, et al. The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol. 2021;50(2):420-9. doi: https://doi.org/10.1093/ije/dyab012
Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389-99. doi: https://doi.org/10.1080/10408363.2020.1770685
Tahery N, Khodadost M, Jahani Sherafat S, Rezaei Tavirani M, Ahmadi N, Montazer F, et al. C-reactive protein as a possible marker for severity and mortality of COVID-19 infection. Gastroenterol Hepatol Bed Bench. 2021 Fall;14(Suppl1):S118-S122.
Sadeghi Mofrad S, Boozarjomehri Amnieh S, Pakzad MR, Zardadi M, Ghazanfari Jajin M, Anvari E, et al. The death rate of COVID-19 infection in different SARS-CoV-2 variants was related to C-reactive protein gene polymorphisms. Sci Rep. 2024;14(1):703. doi: https://doi.org/10.1038/s41598-024-51422-y
COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021;600(7889):472-7. doi: https://doi.org/10.1038/s41586-021-03767-x
Machill A, Bals R, Lammert F, Krawczyk M. Genetic insight into COVID-19 related liver injury: A note on MBOAT7. Liver Int. 2021;41(5):1157-9. doi: https://doi.org/10.1111/liv.14732
Bianco C, Baselli G, Malvestiti F, Santoro L, Pelusi S, Manunta M, et al. Genetic insight into COVID-19-related liver injury. Liver Int. 2021;41(1):227-9. doi: https://doi.org/10.1111/liv.14708
Valenti L, Griffini S, Lamorte G, Grovetti E, Uceda Renteria SC, Malvestiti F, et al. Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19. J Autoimmun. 2021;117:102595. doi: https://doi.org/10.1016/j.jaut.2021.102595
Gorog DA, Storey RF, Gurbel PA, Tantry US, Berger JS, Chan MY, et al. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol. 2022;19(7):475-95. doi: https://doi.org/10.1038/s41569-021-00665-7
Fiorentino G, Benincasa G, Coppola A, Franzese M, Annunziata A, Affinito O, et al. Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism. J Thromb Thrombolysis. 2023;55(1):51-9. doi: https://doi.org/10.1007/s11239-022-02728-z
Jukic I, Heffernan A, Schelling AF, Kokic Males V, Savicevic NJ, Kovacic V. Association between COVID-19 Infection or Vaccination Outcomes and Methylenetetrahydrofolate Reductase Gene Polymorphism: A Systematic Review of the Literature. J Pers Med. 2023;13(12):1687. doi: https://doi.org/10.3390/jpm13121687
Saab YB, Gard PR, Overall AD. The geographic distribution of the ACE II genotype: a novel finding. Genet Res. 2007;89(4):259-67. doi: https://doi.org/10.1017/S0016672307009019
Udomsinprasert W, Nontawong N, Saengsiwaritt W, Panthan B, Jiaranai P, Thongchompoo N, et al. Host genetic polymorphisms involved in long-term symptoms of COVID-19. Emerg Microbes Infect. 2023;12(2):2239952. doi: https://doi.org/10.1080/22221751.2023.2239952
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. doi: https://doi.org/10.1016/S0140-6736(20)30566-3
Abou-Ghaida J, Foster A, Klein S, Bassie M, Gu K, Hille C, et al. The World-Wide Adaptations of Diabetic Management in the Face of COVID-19 and Socioeconomic Disparities: A Scoping Review. Cureus. 2022;14(11):e31911. doi: https://doi.org/10.7759/cureus.31911
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)